Featured Speakers

• 

  Dr Richard BullerVice President, Translational Oncology Pfizer

• 

  Dr Flavia BorelliniSenior Director, Life Cycle Leader, Zelboraf™ Genentech

• 

  Dr Samir HanashProgram Head, Molecular Diagnostics Fred Hutchinson Cancer Research Centre

• 

  Dr Leonard ReynoChief Medical Officer, Oncology Astellas Pharma

Meet the oncology and diagnostics experts you need to deliver better, safer drugs to marker quicker

Molecular Diagnostics for Cancer Drug Development has become the must-attend forum for cancer and diagnostic professionals trying to navigate the biomarker-driven oncology drug development space.  This event will profile those at the cutting-edge of personalized medicine in oncology to give you a thorough review of end to end drug and diagnostic development from discovery to commercialization, including the regulatory environment, pharma/biotech strategies and emerging technologies.  View the full speaker line up.

What's on the agenda?

Overall, the agenda will help you develop your own comprehensive strategy for successfully developing personalized medicines by providing solutions to some of the sector’s biggest challenges. The key questions we’ll be answering are:

• Where are we now with the development, approval and commercialization of companion diagnostics in oncology? What are the different patient stratification strategies companies are taking, both in large pharma and smaller drug developing companies?
• What does the regulatory and reimbursement landscape of CDx development look like? How do we ensure a CDx product gets on to the market and achieves return on investment?
• Prospective versus retrospective biomarker identification and development – what are some of the successes and failures? How have organizations overcome the challenges associated with each approach?
• How do you successfully translate treatment stratification markers from bench to bedside and move from a research grade assay towards a clinically useful diagnostic test?
• What are the latest tools and technologies for molecular profiling and whole genome sequencing? How do we apply them most effectively in personalized medicine development? And what is their diagnostic and clinical utility?

To see exactly who will be answering these questions and what else will be covered you can download the brochure or view the agenda online.

If you’re a drug developer: The agenda, speakers and contacts at this meeting will allow you to develop a comprehensive strategy for integrating predictive biomarkers into your drug development and to deliver a companion diagnostic to market. The agenda will show you how your peers are overcoming the same challenges you are facing and the world leading diagnostic developers will be in the same room to provide solutions. 

If you’re a diagnostics developer: Because of the focus on drug developers’ needs, this meeting creates the perfect environment for you to network with key decision-makers. Oncology drug developers committed to personalized medicine who are looking for solutions. You’ll find yourself having more conversations with drug developers that lead to the prospect of business. You’ll understand the needs of your principal target market. AND learn how other diagnostic developers are addressing the same issues you're facing.

If you’re an innovative technology or service provider: You’ll get to meet the world’s leading diagnostic and drug developers, all under the same roof at the same time.

What's next...

If you would like any more information or to talk to somebody about the meeting then you can contact us on info@hansonwade.com or +1 212 537 5898. Alternatively follow the links below...

View Agenda | Download Brochure | Packages & Prices | Register Now

Networking

	Speed Networking A revolutionary and highly valued way to meet fellow conference attendees in a 60 minute session. Bring lots of business cards! Morning of day one.
	Networking Dinner A fantastic opportunity for in depth discussion in a relaxed, informal and entertaining event at a great local restaurant. End of day one.
	1to1 Networking Use speed networking and the first 2 days to arrange 1to1 networking meetings. Get extended face time with drug and diagnostic developers in a relaxed informal environment. End of day two.
	Drinks Reception A perfect opportunity to relax and unwind with your peers in a casual setting. Meet the people you need to speak to. End of day two.